Dubai – South Korean medical technology firms are aggressively expanding into the Middle East, capitalizing on the region’s substantial investments in healthcare infrastructure and a growing demand for advanced medical solutions. A surge in deals finalized at the recent World Health Expo (WHX) Dubai 2026, formerly known as Arab Health, signals a significant shift in the regional medical device market, traditionally dominated by US and European companies.
Deals secured at WHX Dubai 2026 totaled approximately $2.7 million, according to reports from Korean news agencies. This success underscores the increasing competitiveness of Korean medtech companies and their ability to meet the evolving needs of Middle Eastern healthcare providers. The region is not only expanding hospital capacity but also prioritizing faster diagnostics, improved workflow efficiency, enhanced infection control measures and solutions to address staffing challenges.
Samsung Medison, the imaging unit of Samsung Electronics, prominently featured its latest ultrasound systems at the expo, including the global launch of the V4 and EVO Q10 models, and the Middle Eastern debut of the R20 ultrasound system. The V4 utilizes an AI-focused processor platform developed by Intel, designed to reduce power consumption by 35% compared to previous models while integrating artificial intelligence features. The company emphasized the system’s quieter operation and reduced maintenance requirements, achieved through a fanless design and passive cooling system.
The EVO Q10 is a portable, laptop-style ultrasound system targeted for point-of-care applications in emergency rooms, outpatient clinics, and mobile healthcare settings. Samsung highlighted its portability and ease of cleaning, boasting an IP22 water-resistance rating. These innovations reflect a broader trend within the Korean medtech sector towards developing user-friendly, efficient, and technologically advanced medical devices.
Beyond Samsung, several other Korean firms showcased their capabilities at WHX Dubai 2026. Samyang Biopharm presented its range of surgical sutures and hemostatic agents, aiming to expand its presence in the Middle Eastern market. Dongah Medical showcased its comprehensive medical solutions, signaling a move towards becoming a full-service provider. Quantametrics participated in WHX Labs Dubai, focusing on expanding its business in the region for rapid sepsis diagnostics.
The growing interest from Korean companies comes as the Middle East undergoes a significant transformation in its healthcare landscape. Investments are being directed towards building “smart hospitals” equipped with digital infrastructure, creating opportunities for companies specializing in digital health solutions. The demand for advanced diagnostic tools and treatment options is also increasing, driven by rising healthcare awareness and a growing population.
The shift isn’t limited to large conglomerates like Samsung. Smaller, specialized firms are also finding opportunities. Jeisys Medical Inc., an aesthetic laser maker, is poised to be acquired by French private equity firm Archimed SAS, which manages around €7.5 billion ($7.5 billion) in assets. This acquisition signals growing investor confidence in the Korean aesthetic medical device market.
This expansion into the Middle East aligns with a broader strategy by South Korean companies to diversify their markets and reduce reliance on traditional export destinations. The region’s strong purchasing power and commitment to healthcare innovation make it an attractive target for Korean medtech firms seeking growth opportunities. The Bank of Ayudhya, in its Thailand Industry Outlook 2025-2027, notes a general trend of emerging markets offering significant growth potential, a sentiment echoed by the activity observed at WHX Dubai 2026.
While the US and Europe remain dominant players in the Middle Eastern medical device market, the increasing presence of Korean companies is creating a more competitive landscape. The focus on innovation, coupled with competitive pricing, positions Korean firms to capture a growing share of the market. The success at WHX Dubai 2026 suggests that this trend is likely to continue in the coming years, further solidifying the Middle East as a key growth region for the Korean medical technology industry.
The broader implications of this trend extend beyond the immediate financial gains for Korean companies. It highlights the growing importance of international collaboration in healthcare and the potential for emerging markets to drive innovation in the medical device sector. The Middle East’s commitment to modernizing its healthcare infrastructure is not only improving patient care but also creating new opportunities for companies around the world.
